On 6-8 April 2024, we had the great pleasure of hosting in our Institute distinguished representatives of the world of science as well as Wilson disease patient organisations from Poland, Germany, France and Spain, together with representatives of the “Per Humanus” Foundation. The meeting was organised within the framework of the European Joint Programme Rare Diseases project “Wilson Med – Multi-molecular targeting of copper overload in Wilson disease”, of which the manager in Poland is prof. dr hab. n. med. Piotr Socha, and the main executor is dr. n. wet. Joanna Bierła.

It was a very fruitful three days, during which many issues were raised concerning further action for patients with Wilson disease. Results recently obtained within the Wilson Med project were presented, including new copper chelators, which are a prelude to the development of new therapeutic strategies. We were pleased to present our contribution to the development of new research models, exemplified by cell lines isolated from patients’ urine, and non-invasive diagnostic methods exemplified by new serological markers. We were also able to present our hospital, with particular emphasis on the role of the Paediatric Clinical Research Support Centre. We hope that the aforementioned project and the meeting at the CMHI will contribute to the creation of new projects to support rare disease treatment programmes.